HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Andrew J. Lodge Permission Requests Google Scholar Articles by Lodge, A. J. PubMed Articles by Lodge, A. J. Related Collections Mechanical Circulatory Assistance Related Article

---

Original Articles: Adult Cardiac

Invited Commentary

Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Box 3340, Durham, NC 27710

(Email: andrew.lodge@duke.edu).

The first 20% of the full text of this article appears below.

The use of left ventricular assist devices (LVADs) has become routine practice at many centers around the United States and abroad. This therapy has evolved fairly quickly and the development of new devices has outpaced the regulatory machinery that governs their use. Since the United States Food and Drug Administration approval of the Thoratec Heartmate XVE (Thoratec Corporation, Pleasanton, CA) for destination therapy, there has yet to be another device approved for this purpose. For this reason, as well as the fact that this device remains the . . . [Full Text of this Article]

Related Article

Clinical Experience With Sternotomy Versus Subcostal Approach for Exchange of the HeartMate XVE to the HeartMate II Ventricular Assist Device

Igor D. Gregoric, Brian A. Bruckner, Leon Jacob, Biswajit Kar, William E. Cohn, Saverio La Francesca, and O.H. Frazier
Ann. Thorac. Surg. 2008 85: 1646-1649. [Abstract] [Full Text] [PDF]